Skip to search formSkip to main contentSkip to account menu

certoparin

National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

AnticoagulantsHeparin, Low-Molecular-Weight

Narrower (1)

Certoparin sodium

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
A multi-center, prospective, open-label, 8-week study of certoparin for anticoagulation during maintenance hemodialysis – the membrane study
BackgroundAdequate anticoagulation is prerequisite for effective hemodialysis to prevent clotting in the extracorporeal circuit… 
2010
2010
An open-label comparison of the efficacy and safety of certoparin versus unfractionated heparin for the prevention of thromboembolic complications in acutely ill medical patients: CERTAIN
Objective: Guidelines recommend low-dose unfractionated heparin (UFH) and low-molecular-weight heparin for the prophylaxis of… 
Highly Cited
2008
Highly Cited
2008
Differences between low-molecular-weight and unfractionated heparin for venous thromboembolism prevention following ischemic stroke: a metaanalysis.
BACKGROUND Venous thromboembolism (VTE) remains a major cause of morbidity following stroke. The optimal form of pharmacologic… 
2007
2007
Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects.
Inhalation of heparin results in local antiinflammatory and antifibrotic effects and an inhibition of blood coagulation. A number… 
Highly Cited
2005
Highly Cited
2005
Molecular weight determines the frequency of delayed type hypersensitivity reactions to heparin and synthetic oligosaccharides
Summary Eczematous lesions, resulting from type IV sensitizations are well-known and relatively frequent cutaneous adverse… 
2001
2001
Influence of Low Molecular Weight Heparin (Certoparin) and Unfractionated Heparin on the Release of Cytokines from Human Leukocytes
We analyzed the influence of heparins (unfractionated heparin, UFH and low molecular weight heparin certoparin) on the generation… 
2001
2001
A randomized trial of the low-molecular-weight heparin certoparin to prevent restenosis following coronary angioplasty.
OBJECTIVES The objectives of this study were to evaluate the effectiveness and safety of the low-molecular-weight heparin (LMWH… 
1999
1999
Pharmacologic profile of certoparin.
The low molecular weight heparins (LMWHs) are now not only used for the prophylaxis and treatment of deep vein thrombosis (DVT… 
1999
1999
Comparison of 3,000 IU aXa of the low molecular weight heparin certoparin with 5,000 IU aXa in prevention of deep vein thrombosis after total hip replacement. German Thrombosis Study Group.
BACKGROUND The aim of this randomized, double-blind and prospective clinical trial was to investigate whether an increase of the… 
1997
1997
Topical application of low molecular weight heparin in a rabbit traumatic anastomosis model.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)